Literature DB >> 7362424

Lithium: a brake in the rising cost of mental illness.

A Reifman, R J Wyatt.   

Abstract

Lithium has been extraordinarily successful in the treatment of manic-depression. To compute the economic impact of that success on the United States, an estimate of the cost of care for manic-depression before lithium was introduced was compared with cost estimates after lithium. Economic gains in production were also calculated. Assumptions and exclusions err on the conservative side so that estimates, if inaccurate, are low. The use of lithium as a treatment for manic-depression has saved +2.88 billion in ten years and resulted in a +1.28 billion gain in production, or a conservative total of over +4 billion.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7362424     DOI: 10.1001/archpsyc.1980.01780170027002

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  4 in total

1.  Lithium revisited: savings brought about by the use of lithium, 1970-1991.

Authors:  R J Wyatt; I D Henter; J C Jamison
Journal:  Psychiatr Q       Date:  2001

2.  Divalproex Sodium Versus Valproic Acid in Hospital Treatment of Psychotic Disorders.

Authors:  Thomas L. Schwartz; Jose L. Massa; Sanjay Gupta; Sadiq Al-Samarrai; Patrick Devitt; Prakash S. Masand
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-04

3.  An economic evaluation of manic-depressive illness--1991.

Authors:  R J Wyatt; I Henter
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1995-08       Impact factor: 4.328

4.  Long term effects of lithium on glomerular filtration rate in Indian subjects - a cross sectional study.

Authors:  B Singh; B R Mittal; K Sud; A Bhattacharya; P Sharan; S K Jindal; S D Deodhar
Journal:  Indian J Psychiatry       Date:  2000-10       Impact factor: 1.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.